Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - DoubtfulReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exponent (EXPO) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Exponent (EXPO) over the last 16 years, with Q4 2025 value amounting to $207.4 million.

  • Exponent's Cash & Equivalents fell 561.11% to $207.4 million in Q4 2025 from the same period last year, while for Oct 2025 it was $207.4 million, marking a year-over-year decrease of 561.11%. This contributed to the annual value of $258.9 million for FY2025, which is 3833.88% up from last year.
  • According to the latest figures from Q4 2025, Exponent's Cash & Equivalents is $207.4 million, which was down 561.11% from $231.8 million recorded in Q3 2025.
  • Over the past 5 years, Exponent's Cash & Equivalents peaked at $297.7 million during Q4 2021, and registered a low of $125.6 million during Q1 2023.
  • Moreover, its 5-year median value for Cash & Equivalents was $200.4 million (2021), whereas its average is $198.6 million.
  • Per our database at Business Quant, Exponent's Cash & Equivalents surged by 7474.57% in 2021 and then plummeted by 4576.25% in 2022.
  • Quarter analysis of 5 years shows Exponent's Cash & Equivalents stood at $297.7 million in 2021, then crashed by 45.76% to $161.5 million in 2022, then increased by 15.91% to $187.2 million in 2023, then rose by 17.4% to $219.7 million in 2024, then decreased by 5.61% to $207.4 million in 2025.
  • Its Cash & Equivalents stands at $207.4 million for Q4 2025, versus $231.8 million for Q3 2025 and $245.1 million for Q2 2025.